Source:http://linkedlifedata.com/resource/pubmed/id/19574772
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5
|
pubmed:dateCreated |
2009-7-3
|
pubmed:abstractText |
The peptide hormones inhibin and antimüllerian hormone (AMH), both produced by the granulosa cells, are potential candidates for diagnosis and follow-up of granulosa cell tumors (GCTs). The objective was to evaluate the usefulness of serum levels of inhibin B and AMH in the diagnosis and follow-up of GCT. The review summarizes and discusses the value and limitations of the laboratory tests of these hormones by investigating the performance characteristics of the serum analyses. A search in PubMed database was accomplished to find articles describing serum inhibin and/or AMH as a diagnostic test or for follow-up of GCT. The literature search included articles published between 1989 and September 2008. The sensitivity of inhibin B and AMH for diagnosing patients with a progressive disease is rather equivalent. Antimüllerian hormone is a more specific serum parameter than inhibin, because inhibin may also increase in some (mucinous) epithelial ovarian tumors. Nowadays, specific and ultrasensitive assays are commercially available as well for inhibin B as for AMH, so that early detection of GCT might be possible. For patients with elevated levels of inhibin B and/or AMH at initial diagnosis of GCT, inhibin B and/or AMH seemed to be reliable markers during follow-up for early detection of residual or recurrent disease. Elevated concentrations of these hormones predict relapse earlier than clinical symptoms, which leads to less morbidity of the patients. In conclusion, inhibin B and AMH are both useful serum markers for diagnosis and especially for follow-up of patients with a GCT. Currently, there is no evidence-based preference for inhibin B or AMH as tumor marker.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
1525-1438
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
19
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
847-55
|
pubmed:meshHeading |
pubmed-meshheading:19574772-Anti-Mullerian Hormone,
pubmed-meshheading:19574772-Female,
pubmed-meshheading:19574772-Follow-Up Studies,
pubmed-meshheading:19574772-Granulosa Cell Tumor,
pubmed-meshheading:19574772-Humans,
pubmed-meshheading:19574772-Inhibins,
pubmed-meshheading:19574772-Ovarian Neoplasms,
pubmed-meshheading:19574772-Prognosis,
pubmed-meshheading:19574772-Tumor Markers, Biological
|
pubmed:year |
2009
|
pubmed:articleTitle |
The role of inhibins B and antimüllerian hormone for diagnosis and follow-up of granulosa cell tumors.
|
pubmed:affiliation |
Laboratory Medicine, Division of Gynecologic Oncology, University Hospitals Leuven, Leuven, Belgium.
|
pubmed:publicationType |
Journal Article
|